Related Experiment Video
Updated: Jan 8, 2026
High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
Genotoxic Drug-Induced Hepatotoxicity: An In Silico Prediction Using Rattus norvegicus Microarray Gene Expression
C P Sri Snehaa1, Palanisamy Rajaguru2, Velan Pugalenthi1
1Department of Biotechnology, University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli, Tamil Nadu, India.
Abstract:
Most genotoxic compounds are potentially used for therapeutic purposes against various diseases, particularly cancer types, either alone or in combination with other drugs. However, these drug combinations have detrimental adverse effects during or post the treatment procedures. To deeply understand the molecular mechanisms underlying the onset or progression of toxicity upon drug treatment, the current work establishes a systematic in silico approach that applies the microarray gene expression data to predict specific mechanisms through which hepatotoxicity is induced. To achieve this, about six in vivo genotoxic drugs are selected such as three chemotherapeutic drugs (cyclophosphamide [CP], cisplatin [CPT], and etoposide [ETP]) and three antibiotic drugs (ethionamide [ETO], chloramphenicol [CPL], and erythromycin ethyl succinate [EES]) based on their direct or indirect mechanisms in inducing hepatotoxicity. Rattus norvegicus liver tissue microarray expression datasets for the selected genotoxic drugs that are available in the Open Toxicogenomics Project-Genomics Assisted Toxicity Evaluation Systems (Open TG-GATES) database have been unpacked using robust software such as dChip and R to identify the differentially expressed genes (DEGs). Further, protein-protein interaction (PPI) networks are constructed, and the genotoxic drugs are functionally analyzed for Gene Ontology Biological Process (GOBP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) using the STRING v12 database. The study has been extended to principal component analysis (PCA) wherein the genotoxic drugs are combined to examine the effects of combinations against hepatotoxicity. The study concludes that 4 of the 15 combinations-CPT/CPL, CP/CPT, EES/CP, and ETP/CPL-possess the potency in causing hepatotoxicity, possibly through chemical carcinogenesis and reactive oxygen species (ROS) receptor activation mechanism leading to genotoxic drug-induced liver injury.
Insights
This study used computational methods to identify genotoxic drug combinations that cause liver toxicity. Four combinations were found to induce hepatotoxicity, potentially via chemical carcinogenesis and ROS activation.
Area of Science:
- Toxicology
- Computational Biology
- Pharmacology
Background:
- Genotoxic compounds are used therapeutically but can cause adverse effects, particularly hepatotoxicity.
- Understanding the molecular mechanisms of drug-induced toxicity is crucial for safe therapeutic use.
Purpose of the Study:
- To establish a systematic in silico approach to predict hepatotoxicity mechanisms induced by genotoxic drugs.
- To identify specific genotoxic drug combinations that cause liver injury.
Main Methods:
- Utilized microarray gene expression data from Rattus norvegicus liver tissues exposed to six genotoxic drugs.
- Employed dChip and R for differential gene expression analysis, STRING for protein-protein interaction (PPI) network construction, and KEGG/GOBP for functional analysis.
- Applied principal component analysis (PCA) to evaluate drug combinations for hepatotoxicity.
Main Results:
- Identified differentially expressed genes (DEGs) and constructed PPI networks for selected genotoxic drugs.
- Functional analysis revealed potential mechanisms of hepatotoxicity.
- Four out of 15 drug combinations (cisplatin/chloramphenicol, cyclophosphamide/cisplatin, erythromycin ethyl succinate/cyclophosphamide, etoposide/chloramphenicol) showed significant potential for causing hepatotoxicity.
Conclusions:
- The study successfully predicted hepatotoxicity mechanisms using an in silico approach.
- Identified specific drug combinations that pose a risk for liver injury.
- Hepatotoxicity may result from chemical carcinogenesis and reactive oxygen species (ROS) receptor activation.
